Author:
Nie Wei,Xu Mi-Die,Gan Lu,Zhang Yi,Qian Jie,Gu Kai,Zhang Xue-Yan,Wang Hui-Min,Yan Bo,Gu Ping,Zhang Bo,Wang Shu-Yuan,Hu Fang,Li Chang-Hui,Zhong Hua,Han Bao-Hui
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology,Immunology,Immunology and Allergy
Reference35 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. NCCN guidelines insights: non–small cell lung cancer, version 1.2020;Ettinger;J Natl Compr Canc Netw,2019
3. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016
4. NCCN guidelines updates: new immunotherapy strategies for improving outcomes in non–small cell lung cancer;Gubens;J Natl Compr Canc Netw,2019
5. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N Engl J Med,2015
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献